Celdara Medical (OnCyte) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Celdara Medical (OnCyte) General Information

Description

Developer of treatments in the field of immuno-oncology. The business unit has developed the most advanced autologous CAR (chimeric antigen receptor) T-Cell drug candidate uses a specific human Natural Killer cell receptor that targets tumor antigens expressed in most liquid and solid cancers.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • Lebanon, NH
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celdara Medical (OnCyte) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Celdara Medical (OnCyte)‘s full profile, request access.

Request a free trial

Celdara Medical (OnCyte) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Celdara Medical (OnCyte)‘s full profile, request access.

Request a free trial

Celdara Medical (OnCyte) FAQs

  • Where is Celdara Medical (OnCyte) headquartered?

    Celdara Medical (OnCyte) is headquartered in Lebanon, NH.

  • What industry is Celdara Medical (OnCyte) in?

    Celdara Medical (OnCyte)’s primary industry is Biotechnology.

  • Is Celdara Medical (OnCyte) a private or public company?

    Celdara Medical (OnCyte) is a Private company.

  • What is the current valuation of Celdara Medical (OnCyte)?

    The current valuation of Celdara Medical (OnCyte) is 00000.

  • What is Celdara Medical (OnCyte)’s current revenue?

    The current revenue for Celdara Medical (OnCyte) is 000000.

  • Who are Celdara Medical (OnCyte)’s investors?

    Celdara Medical has invested in Celdara Medical (OnCyte).

  • When was Celdara Medical (OnCyte) acquired?

    Celdara Medical (OnCyte) was acquired on 06-Jan-2015.

  • Who acquired Celdara Medical (OnCyte)?

    Celdara Medical (OnCyte) was acquired by Celyad Oncology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »